SN101 iPSC-derived therapy relieves chronic pain and preserves joints

	Arthritis
	The latest arthritis news from News Medical

	SN101 iPSC-derived therapy relieves chronic pain and preserves joints SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on a novel approach to chronic pain management and joint tissue preservation.

	Why female athletes need injury prevention rules built for women, not men This International Olympic Committee consensus synthesised evidence from over 600 studies to develop 56 injury prevention recommendations tailored to female, woman and girl athletes. It concludes that reducing injury risk requires a whole sports system approach that integrates training, policy, environment and culture, not exercise alone.

			Wheelchair? Hearing aids? Yes. ‘Disabled?' No way. In her house in Ypsilanti, Michigan, Barbara Meade said, "there are walkers and wheelchairs and oxygen and cannulas all over the place."

			EULAR proposes new guidance to assess disease activity in adult-onset Still’s disease EULAR - The European Alliance of Associations for Rheumatology - has identified an unmet clinical need around the assessment of disease activity in people with adult-onset Still's disease.

			TikTok videos about gout often contain misleading information A new paper in Rheumatology Advances in Practice, published by Oxford University Press, indicates that TikTok videos about gout are commonly misleading, inconsistent, or inaccurate.

	Psoriasis and advancing skin health Psoriasis is a chronic, recurrent autoimmune disease impacting over 125 million people worldwide.

	Arthritis and safeguarding joint health Arthritis is a systemic autoimmune disorder that can also affect the heart, lungs, and other organs.

	In the vast expanses of Indian country, broadband gaps create health gaps, too Standing atop Ferry Butte, Frances Goli scanned the more than half a million acres of Shoshone-Bannock tribal land below as she dug her hands into the pockets of a pink pullover.

	Nanozyme Hydrogel Directly Targets Cause of Diabetic Osteoarthritis A nanozyme-integrated hydrogel targets AGEs in diabetic osteoarthritis, enhancing cartilage function and mobility in diabetic models through innovative therapy.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026